Broadcaster: Peptech (ASX: PTD)
Broadcast Title: Shareholders Approve Peptech-Evogenix Merger
Broadcast Type: Audio stream
Audio webcast Link:
http://abnnewswire.net/alnk/H0D7L84T
Listen to the Audio stream and view the announcement for Peptech (ASX: PTD) below.
http://abnnewswire.net/vlnk/6J8LFO53
This Audio Cast is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
Minimum requirement for playing the multimedia links are; at least a 28.8k modem and sufficient memory and hard disk space to run Windows Media Player or Real Player. In addition, some media links contain material requiring the ability to run Flash Multimedia.
About Arana Therapeutics Limited
About Peptech
Peptech Limited focuses on the research and development of peptides and proteins in the areas of human pharmaceuticals and animal health. Peptech holds a 36.1 per cent shareholding in Domantis, a UK-based drug development company, and has formed a 50/50 joint venture company with Biosceptre. The company is positioned to become a globally recognised leader in biopharmaceutical development. For more information, please visit www.peptech.com.
Related Companies
